<DOC>
	<DOC>NCT00304252</DOC>
	<brief_summary>The purpose of this study is to determine the safety and efficacy of interferon beta-1a in maintaining remission in patients with Crohn's disease.</brief_summary>
	<brief_title>Safety and Efficacy of Treatment With Interferon Beta-1a RebifÂ® in Patients With Crohn's Disease</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-beta</mesh_term>
	<mesh_term>Interferon beta-1a</mesh_term>
	<criteria>Patients with an established diagnosis of Crohn's disease who went into remission using corticosteroids within 4 weeks before the study Any other treatment for the maintenance of remission of Crohn's disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>